7Baggers

We provide you with 20 years of free, institutional-grade data for BBIO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BBIO. Explore the full financial landscape of BBIO stock.

Reported DateCIKTickerType
2025-08-051743881BBIO10-QUrl
2025-04-291743881BBIO10-QUrl
2025-02-201743881BBIO10-KUrl
2024-11-121743881BBIO10-QUrl
2024-08-011743881BBIO10-QUrl
2024-05-021743881BBIO10-QUrl
2024-02-221743881BBIO10-KUrl
2023-11-021743881BBIO10-QUrl
2023-08-031743881BBIO10-QUrl
2023-05-041743881BBIO10-QUrl
2023-02-231743881BBIO10-KUrl
2022-11-031743881BBIO10-QUrl
2022-08-041743881BBIO10-QUrl
2022-05-051743881BBIO10-QUrl
2022-02-251743881BBIO10-KUrl
2021-11-041743881BBIO10-QUrl
2021-08-051743881BBIO10-QUrl
2021-05-061743881BBIO10-QUrl
2021-02-251743881BBIO10-KUrl
2020-11-051743881BBIO10-QUrl
2020-08-111743881BBIO10-QUrl
2020-05-141743881BBIO10-QUrl
2020-03-031743881BBIO10-KUrl
2019-11-081743881BBIO10-QUrl
2019-08-141743881BBIO10-QUrl
2019-05-241743881BBIOS-1Url

BridgeBio Pharma, Inc
(NASDAQ:BBIO) 

BBIO stock logo

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs inc...

Founded: 2015
IPO Price: $17 (Jun 27, 2019)
Full Time Employees: 369
CEO: Neil Kumar  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about BBIO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.